New Market Research Report: PharmaPoint: HIV - Current and Future Players

Fast Market Research recommends "PharmaPoint: HIV - Current and Future Players" from GlobalData, now available

by Bill Thompson

(WireNews+Co) - Boston, MA - 22 March 2013

GlobalData has released its pharma report, "PharmaPoint: HIV - Current and Future Players". The report is a vital source of up-to-date information with in-depth analysis on the companies in the rapidly growing HIV Market. The report identifies and analyses the key companies shaping and driving the global HIV market. The report provides insight into the competitive HIV landscape, including new companies entering the market. This report is built using data and information sourced from proprietary databases, primary and secondary and in-house analysis by GlobalData's team of industry experts.

Scope

- Investigation of current and future market competition for HIV
- Competitor assessment
- Coverage of key market players and company profiles including business description, financial overview and SWOT analysis.
- Strategic assessment of the HIV sector through market impact analysis, future market scenario and company analysis

View Full Report Details (http://www.fastmr.com/prod/553300_pharmapoint_hiv_current_and_future_players.aspx?afid=201) (http://www.fastmr.com/prod/553300_pharmapoint_hiv_current_and_future_players.aspx?afid=201)

Reasons to buy

- Gain a high level view of the trends shaping and driving the HIV Market
- Assess competitiveness of products in market by understanding the strengths and weaknesses of current competition.
- Create an effective counter-strategy to gain a competitive advantage against those currently in the market
- What's the next big thing in the global HIV market landscape? Identify, understand and capitalize

Companies Mentioned in this Report: Gilead, ViiV Healthcare, AbbVie (Abbott), Merck, Janssen (a Subsidiary of J&J), Bristol-Myers Squibb, Japan Tocacco

Partial Table of Contents:

1 Table of Contents
1 Table of Contents
1.1 List of Tables
1.2 List of Figures
2 Introduction
2.1 Catalyst
2.2 Related Reports
3 Market Outlook
3.1 Global Markets
3.1.1 Forecast
3.1.2 Drivers and Barriers - Global Issues
4 Current and Future Players
4.1 Overview
4.2 Trends in Corporate Strategy
4.3 Company Profiles
4.3.1 Gilead
4.3.2 ViiV Healthcare
4.3.3 AbbVie (Abbott)
4.3.4 Merck
4.3.5 Janssen (a Subsidiary of J&J)
4.3.6 Bristol-Myers Squibb
4.3.7 Japan Tocacco
5 Appendix
5.1 Bibliography
5.2 Abbreviations
5.3 Methodology
5.4 Forecasting Methodology
5.4.1 HIV Prevalence
5.4.2 Percent Drug-Treated Patients
5.4.3 Drugs Included in Each Therapeutic Class
5.4.4 Launch and Patent Expiry Dates
5.4.5 General Pricing Assumptions
5.4.6 Individual Drug Assumptions
5.4.7 Generic Erosion
5.4.8 Pricing of Pipeline agents
5.5 Physicians and Specialists Included in this Study
5.5.1 Survery of Prescribing Physicians
5.6 About the Authors
5.6.1 Authors
5.6.2 Epidemiologists
5.6.3 Global Head of Healthcare
5.7 About GlobalData
5.8 Contact Us
5.9 Disclaimer

List of Tables

1.1 List of Tables
Table 1: Global Sales Forecasts ($m) for HIV, 2012-2022
Table 2: Global HIV Market - Drivers and Barriers, 2012-2022
Table 3: Key Companies in the HIV Market, 2012
Table 4: Gilead's HIV Therapy Portfolio Assessment, 2012
Table 5: Gilead SWOT Analysis, 2012
Table 6: ViiV Healthcare's HIV Therapy Portfolio Assessment, 2012
Table 7: ViiV Healthcare SWOT Analysis, 2012
Table 8: AbbVie's HIV Therapy Portfolio Assessment, 2012
Table 9: AbbVie SWOT Analysis, 2012
Table 10: Merck's HIV Therapy Portfolio Assessment, 2012
Table 11: Merck SWOT Analysis, 2012

View Full Table of Contents



(http://www.fastmr.com/catalog/product.aspx?productid=553300&dt=t&afid=201)

Fast Market Research (http://www.fastmr.com?afid=201) is an online aggregator and distributor of market research and business information. Representing the world's top research publishers and analysts, we provide quick and easy access to the best competitive intelligence available. Our unbiased, expert staff will help you find the right research to fit your requirements and your budget.  For more information about these or related research reports, please visit our website at http://www.fastmr.com or call us at 1.800.844.8156.